Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

Cardiac surgery - patient information

Description: The aim of this book is to give you written advice about recovery following cardiac surgery. We know that for many
Url: /Media/UHS-website-2019/Patientinformation/Heartandlungs/Cardiacsurgery-1362-PIL.pdf

Glofitamab-Obinutuzumab

Description: Chemotherapy Protocol LYMPHOMA GLOFITAMAB-OBINUTUZUMAB Regimen • Lymphoma-Glofitamab-Obinutuzumab Indication • Treatment of adult patients with relapsed or refractory diffuse large B
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Glofitamab-Obinutuzumab.pdf

DVd_Twice weekly_Daratumumab-Bortezomib-Dexamethasone_Cycles 1 to 8

Description: Chemotherapy Protocol Myeloma DVd (twice weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (twice weekly)-Daratumumab-Dexamethasone Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Twice-weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

VenetoclaxHigh

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (high risk) Regimen • CLL – Venetoclax (high risk) Indication • Venetoclax is indicated for the treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxHigh.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone Cycles 1 to 8

Description: Chemotherapy Protocol Myeloma DVd (Weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (weekly)-Daratumumab-Dexamethasone Indication • Daratumumab in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

ObinutuzumabVenetoclax LowRisk

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Obinutuzumab-Venetoclax (Low Risk) Regimen • CLL – Obinutuzumab-Venetoclax (Low Risk) Indication • Chronic lymphatic leukaemia (CLL) or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/ObinutuzumabVenetoclax-LowRisk.pdf

ACCORD-2 master protocol

Description: CONFIDENTIAL ACCORD-2-001 – Master Protocol TITLE PAGE Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study
Url: /Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-master-protocol.pdf

Extensor tendon repair (zones 4 to 7) - Norwich regime or controlled active motion regime) - patient information

Description: This factsheet explains what the Norwich regime (also known as the controlled active motion regime) rehabilitation programme is and what it
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Extensor-tendon-repair-zones-4-to-7-Norwich-regime-or-controlled-active-motion-regime-3962-PIL.pdf

Recovering from heart surgery - Mindful movement for moving, lifting and physical activity - patient information

Description: This factsheet contains important information about movement, lifting and physical activity while you are recovering from heart surgery.
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Recovering-from-heart-surgery-Mindful-movement-for-moving-lifting-and-physical-activity-3135-PIL.pdf

MUTYH associated polyposis (MAP) - patient information

Description: This booklet contains information about a condition called MUTYH associated polyposis (MAP).
Url: /Media/UHS-website-2019/Patientinformation/Genetics/MUTYH-associated-polyposis-MAP-3201-PIL.pdf

341 to 350 of 941

Previous … 33 34 35 36 37 … Next